Correlation Between Australia and Actinogen Medical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Australia and Actinogen Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Australia and Actinogen Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Australia and New and Actinogen Medical, you can compare the effects of market volatilities on Australia and Actinogen Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Australia with a short position of Actinogen Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Australia and Actinogen Medical.

Diversification Opportunities for Australia and Actinogen Medical

-0.25
  Correlation Coefficient

Very good diversification

The 3 months correlation between Australia and Actinogen is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Australia and New and Actinogen Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Actinogen Medical and Australia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Australia and New are associated (or correlated) with Actinogen Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Actinogen Medical has no effect on the direction of Australia i.e., Australia and Actinogen Medical go up and down completely randomly.

Pair Corralation between Australia and Actinogen Medical

Assuming the 90 days trading horizon Australia and New is expected to generate 0.13 times more return on investment than Actinogen Medical. However, Australia and New is 7.66 times less risky than Actinogen Medical. It trades about 0.08 of its potential returns per unit of risk. Actinogen Medical is currently generating about 0.01 per unit of risk. If you would invest  2,123  in Australia and New on September 3, 2024 and sell it today you would earn a total of  994.00  from holding Australia and New or generate 46.82% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Australia and New  vs.  Actinogen Medical

 Performance 
       Timeline  
Australia and New 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Australia and New are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Australia is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Actinogen Medical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Actinogen Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Australia and Actinogen Medical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Australia and Actinogen Medical

The main advantage of trading using opposite Australia and Actinogen Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Australia position performs unexpectedly, Actinogen Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Actinogen Medical will offset losses from the drop in Actinogen Medical's long position.
The idea behind Australia and New and Actinogen Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.

Other Complementary Tools

Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like